Core Committee (L-R): Fetene Tekle (Janssen), Gareth Thomas (Covance), Bernd Igl (Boehringer Ingelheim), Eloisa Brook (GlaxoSmithKline), Jim Saul (Covance) and Phillip Jarvis (Novartis). Natasha Karp (Astrazeneca) has also recently joined the SIG.
To provide a forum to discuss and advance statistical topics related to Research, Discovery (including efficacy models), Regulatory and Investigative Toxicology/Safety Assessment and to promote the involvement of Statisticians in these areas.
Our membership consists of statisticians at CROs, pharmaceutical companies and academia who are working in areas such as:
- Discovery
- Good statistical practice in in-vitro, ex-vivo and in-vivo assay development
- Reproducibility and Translation from pre-clinical to clinical
- Toxicogenomics
- Genetic Toxicology
- Acute Toxicology
- General Toxicology
- Eco-Toxicology
- Toxicokinetics
- DMPK / Pharmacokinetics
- ECG
- Immuno Toxicology
- Histopathology
- Pharmacology
- Developmental and Reproductive Toxicology
- Carcinogenicity
We discuss diverse topics ranging from Dog Telemetry data analysis to Decision Trees, from Bayesian methods to dealing with irate study directors, and now have a list of over 50 affiliates on our e-mail distribution list.
Find out more in our video overview:
The PSI Pre-clinical Special Interest Group have a series of regular FREE webinars dealing with statistical topics faced in pre-clinical and related fields. The presentations will run for an hour, with approximately 45 min presentation and a Q&A session in the remaining time. See section below for details of this year’s webinars.
The PSI Pre-Clinical Special Interest Group seminars for 2021 are as follows:
Date | Title | Presenter | Slides/Video on Demand |
16 Mar | Beyond the looking glass – Interpreting animal welfare & behaviour by monitoring & assessing mice activity data | Eloisa Brook, Joanna Moore, George Birbeck. GSK | VoD |
29 Jun | Update from the Carcinogenicity working group | Steve Bailey. Pfizer | VoD |
12 Oct | Therioepistomology | Dr Brianna Gaskill. Novartis |
|
For all previous webinars click here.
We are already planning for when we are able to hold face-to-face workshops again. Watch this space.
Join our mailing list by e-mailing this address with brief details of the field(s) you are working in.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
PSI are starting a book club! We will be reading/discussing non-technical books relevant to our roles. Participants will be split into smaller groups to network with each other and practice exercises.
Whatever your current challenge(s) at work, this workshop will explore what's holding you back, and how barriers can be removed in order to progress and achieve.
A PSI Training Course covering the statistical methods for repeated measures and other clustered data. Course will cover: Conditional models for continuous hierarchical data, Conditional models for continuous longitudinal data, Marginal models (GEE) for continuous longitudinal data & Discrete data.
Learn from others in the PSI Community who also associate with Imposter Syndrome. They will discuss the topic, give their own personal views and experiences and provide tips to beat it.
Complex Innovative Designs: overview and case studies from FDA pilot program and considerations on master protocols.
R is quickly gaining popularity within the pharmaceutical industry due to it being a very powerful object-orientated language, and is able to produce analyses and high quality graphics. This will be a hands-on interactive course and will utilise the RStudio Cloud development environment.
In just 1 hour, learn about the field of medical statistics and how it plays a crucial role in developing ground-breaking new medicines, vaccines and healthcare products.
Our annual PSI Medical Statistics Careers Event, will be held online on Wednesday 2nd March 2022. The event will include a live online panel discussion and a virtual exhibition session.
For our global team in Europe we are seeking highly qualified candidates to fill the position of Global Director Biostatistics (m/f/x).
Joining us as Principal Biostatistician you will be responsible for providing statistical support of global clinical development programs in neuroscience.
The Senior Manager Biostatistics will be responsible for leading biostatistics strategy and activities for a compound and/or for individual clinical studies.
Novartis is establishing a virtual Analytics Network in the UK and we are currently recruiting PhD graduates to join this exciting new group!
